State Board Of Administration Of Florida Retirement System Arbutus Biopharma Corp Transaction History

State Board Of Administration Of Florida Retirement System

$53.7 Billion
Q1 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2023 Nov 08, 2023	BUY	$1.9 - $2.27 $741 - $885	390 Added 1.1%	35,820 $72,000
Q2 2023 Aug 11, 2023	BUY	$2.24 - $3.06 $79,363 - $108,415	35,430 New	35,430 $81,000

Others Institutions Holding ABUS

# of Institutions

130

Shares Held

82.2M

Call Options Held

4.82M

Put Options Held

546K

Whitefort Capital Management, LP New York, NY

12.9M
Shares

$41.9 Million
24.48% of portfolio
Black Rock Inc. New York, NY

10.4M
Shares

$33.9 Million
0.0% of portfolio
Morgan Stanley New York, NY

8.83M
Shares

$28.8 Million
0.0% of portfolio
Two Seas Capital LP Rye, NY

7.84M
Shares

$25.6 Million
10.39% of portfolio
Vanguard Group Inc Valley Forge, PA

5.99M
Shares

$19.5 Million
0.0% of portfolio

View Full List

About Arbutus Biopharma Corp

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $489M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

More about ABUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.

Account